The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

Since assuming the CEO role in 2021, Schweizer has driven BCG's growth, expanding BCG's consulting team every year. His second term begins on October 1, 2025. "I am honored to continue leading BCG ...

Adjuvant, intravesical bacillus Calmette–Guérin (BCG) therapy reduces the risk of recurrence and progression of superficial bladder cancer, but confers a considerable risk of local and systemic ...